{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:54:36Z","timestamp":1766400876530,"version":"3.41.2"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD) are closely associated. However, membranous nephropathy (MN), one of the causes of CKD, may contribute to NAFLD through abnormalities in lipid metabolism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>93 patients diagnosed with MN by renal biopsy and admitted to Henan Provincial People\u2019s Hospital between August 2021 and August 2022 were enrolled in this study. Patients were divided into two groups based on the presence or absence of NAFLD. Publicly available datasets related to NAFLD and MN were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified, and weighted gene co-expression network analysis (WGCNA) was conducted to identify module genes. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed. A protein-protein interaction (PPI) network was constructed, and key genes associated with both diseases were identified using Cytoscape software and machine learning algorithms. The correlation between immune cell infiltration and the two diseases was evaluated using the CIBERSORT algorithm. Finally, the key gene expression was validated using external datasets and immunohistochemistry (IHC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with the non-NAFLD group, patients in the NAFLD group had significantly higher body weight, hemoglobin levels, triglycerides, and complement C3 and C4 levels. Conversely, IgG levels were significantly lower in the NAFLD group. A total of 211 shared DEGs were identified between MN and NAFLD, including 175 upregulated and 36 downregulated genes. Enrichment analysis indicated that these genes were primarily involved in immune and inflammatory responses. PPI network analysis identified seven hub genes: <jats:italic>CSF1R<\/jats:italic>, <jats:italic>FCGR1G<\/jats:italic>, <jats:italic>FCGR3A<\/jats:italic>, <jats:italic>VAV1<\/jats:italic>, <jats:italic>SPI1<\/jats:italic>, <jats:italic>HCK<\/jats:italic>, and <jats:italic>CCR1<\/jats:italic>. Among them, <jats:italic>CSF1R<\/jats:italic> was identified as the key gene using a machine learning approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study suggests that CSF1R is a shared molecular of MN and NAFLD, which may serve as a potential therapeutic target for patients affected by both diseases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1564288","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T05:16:18Z","timestamp":1749100578000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of key genes in membranous nephropathy and non-alcoholic fatty liver disease by bioinformatics and machine learning"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiachen","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2020111583","article-title":"Primary nephrotic syndrome and risks of eskd, cardiovascular events, and death: the kaiser permanente nephrotic syndrome study","volume":"32","author":"Go","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/ede.0000000000001576","article-title":"Twenty-four-year trends in incidence and mortality of nephrotic syndrome: A population-based cohort study","volume":"34","author":"Vestergaard","year":"2023","journal-title":"Epidemiology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease \u2013 a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: definition and subtypes","volume":"29","author":"Han","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"B9","article-title":"Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome","volume":"5","author":"Han","year":"2013","journal-title":"Am J Transl Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12882-025-04022-5","article-title":"Higher triglyceride-glucose index is associated with severe proteinuria and decreased renal function in patients with primary membranous nephropathy","volume":"26","author":"Gao","year":"2025","journal-title":"BMC Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133649","article-title":"The role of insulin resistance in fueling nafld pathogenesis: from molecular mechanisms to clinical implications","volume":"11","author":"Palma","year":"2022","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11030155","article-title":"Insulin resistance across the spectrum of nonalcoholic fatty liver disease","volume":"11","author":"Armandi","year":"2021","journal-title":"Metabolites"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab046","article-title":"Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease","volume":"36","author":"Triozzi","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v15.i2.265","article-title":"Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study","volume":"15","author":"Onwuzo","year":"2023","journal-title":"World J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00358.2018","article-title":"Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals","volume":"316","author":"Suppli","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2021060784","article-title":"Molecular characterization of membranous nephropathy","volume":"33","author":"Sealfon","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27695","article-title":"Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic N-3 and N-6 polyunsaturated fatty acids","volume":"61","author":"Arendt","year":"2015","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212935","article-title":"Metabolic pathways and immunometabolism in rare kidney diseases","volume":"77","author":"Grayson","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1940","article-title":"Transcriptomic profiling of a multiethnic pediatric nafld cohort reveals genes and pathways associated with disease","volume":"6","author":"Yao","year":"2022","journal-title":"Hepatol Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","article-title":"Wgcna: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for rna-seq data with deseq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-985X.2010.00676_9.x","article-title":"Ggplot2: elegant graphics for data analysis","volume":"174","author":"Ginestet","year":"2011","journal-title":"J R Stat Soc Ser A: Stat Soc"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"Clusterprofiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"Cytohubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0270-9295(03)00058-5","article-title":"Hyperlipidemia and thrombotic complications in patients with membranous nephropathy","volume":"23","author":"Nickolas","year":"2003","journal-title":"Semin Nephrol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00518.x","article-title":"Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan","volume":"65","author":"Shiiki","year":"2004","journal-title":"Kidney Int"},{"key":"B30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/1751-2980.12646","article-title":"Serum levels of immunoglobulins in an adult population and their relationship with nonalcoholic fatty liver disease","volume":"19","author":"Sun","year":"2018","journal-title":"J Dig Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i43.7563","article-title":"Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study","volume":"27","author":"De Roza","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.51821\/87.2.12205","article-title":"Different aspects of immunological profile in patients with non-alcoholic fatty liver disease","volume":"87","author":"Osman","year":"2024","journal-title":"Acta Gastroenterol Belg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/srep23279","article-title":"Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population","volume":"6","author":"Xu","year":"2016","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23228","article-title":"Activation of the complement system in human nonalcoholic fatty liver disease","volume":"50","author":"Rensen","year":"2009","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155718","article-title":"Interplay of lipid metabolism and inflammation in podocyte injury","volume":"150","author":"Luo","year":"2024","journal-title":"Metabolism"},{"key":"B37","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"Nlrp3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41419-020-2472-6","article-title":"Neddylation of sterol regulatory element-binding protein 1c is a potential therapeutic target for nonalcoholic fatty liver treatment","volume":"11","author":"Ju","year":"2020","journal-title":"Cell Death Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.10.038","article-title":"Involvement of glomerular srebp-1c in diabetic nephropathy","volume":"364","author":"Ishigaki","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of ppar\u03b1 Action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J Hepatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108391","article-title":"Ppar-\u0393 Signaling in nonalcoholic fatty liver disease: pathogenesis and therapeutic targets","volume":"245","author":"Chen","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.832732","article-title":"The role of peroxisome proliferator-activated receptors in kidney diseases","volume":"13","author":"Gao","year":"2022","journal-title":"Front Pharmacol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphys.2024.100133","article-title":"How ppar-alpha mediated inflammation may affect the pathophysiology of chronic kidney disease","volume":"8","author":"Masenga","year":"2025","journal-title":"Curr Res Physiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114884","article-title":"Csf1r inhibitors are emerging immunotherapeutic drugs for cancer treatment","volume":"245","author":"Wen","year":"2023","journal-title":"Eur J Medicinal Chem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00873","article-title":"Recent advances of colony-stimulating factor-1 receptor (Csf-1r) kinase and its inhibitors","volume":"61","author":"El-Gamal","year":"2018","journal-title":"J Medicinal Chem"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7150\/thno.50683","article-title":"The twin cytokines interleukin-34 and csf-1: masterful conductors of macrophage homeostasis","volume":"11","author":"Mu\u00f1oz-Garcia","year":"2021","journal-title":"Theranostics"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.295","article-title":"Proximal tubule-derived colony stimulating factor-1 mediates polarization of renal macrophages and dendritic cells, and recovery in acute kidney injury","volume":"88","author":"Wang","year":"2015","journal-title":"Kidney Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.08.019","article-title":"Csf-1r inhibition attenuates renal and neuropsychiatric disease in murine lupus","volume":"185","author":"Chalmers","year":"2017","journal-title":"Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.02.010","article-title":"Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis","volume":"106","author":"Cruzado","year":"2024","journal-title":"Kidney Int"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1252347","article-title":"Identification of biomarkers related to immune and inflammation in membranous nephropathy: comprehensive bioinformatic analysis and validation","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1590\/s0101-28002011000300012","article-title":"Inflammation in chronic kidney disease: the role of cytokines","volume":"33","author":"Vianna","year":"2011","journal-title":"J Bras Nefrol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5270657","article-title":"Circulating cd14(+)Cd163(+)Cd206(+) M2 monocytes are increased in patients with early stage of idiopathic membranous nephropathy","volume":"2018","author":"Hou","year":"2018","journal-title":"Mediators Inflammation"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(89)80024-1","article-title":"Immune mechanisms in idiopathic membranous nephropathy: the role of the interstitial infiltrates","volume":"13","author":"Alexopoulos","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S404591","article-title":"The value of peripheral blood cell ratios in primary membranous nephropathy: A single center retrospective study","volume":"16","author":"Zhang","year":"2023","journal-title":"J Inflammation Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/srep28814","article-title":"Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Shoji","year":"2016","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4321\/s1130-01082008000400004","article-title":"Gene expression in obese patients with non-alcoholic steatohepatitis","volume":"100","author":"Cay\u00f3n","year":"2008","journal-title":"Rev Esp Enferm Dig"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1177\/15353702211055099","article-title":"Bioinformatics analysis of an animal model of diet-induced nonalcoholic fatty liver disease with rapid progression","volume":"247","author":"Hong","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177424","article-title":"Arctiin attenuated nash by inhibiting glycolysis and inflammation via fgfr2\/csf1r signaling","volume":"996","author":"Fu","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1444198","article-title":"Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy","volume":"12","author":"Tian","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1195699","article-title":"Macrophages and the development and progression of non-alcoholic fatty liver disease","volume":"14","author":"Alabdulaali","year":"2023","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2005.04.003","article-title":"Vav-family proteins in T-cell signalling","volume":"17","author":"Tybulewicz","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.04.021","article-title":"Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer","volume":"54","author":"Buechler","year":"2021","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1084\/jem.20020873","article-title":"Constitutive activation of the src family kinase hck results in spontaneous pulmonary inflammation and an enhanced innate immune response","volume":"196","author":"Ernst","year":"2002","journal-title":"J Exp Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154174","article-title":"Prognostic and immunological role of fcer1g in pan-cancer","volume":"240","author":"Zhang","year":"2022","journal-title":"Pathol - Res Pract"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.900699","article-title":"Integrative pan-cancer analysis confirmed that fcgr3a is a candidate biomarker associated with tumor immunity","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009983","article-title":"Spi1(+)Cd68(+) macrophages as a biomarker for gastric cancer metastasis: A rationale for combined antiangiogenic and immunotherapy strategies","volume":"12","author":"Deng","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1424308","article-title":"Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1564288\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T05:16:20Z","timestamp":1749100580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1564288\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2025.1564288"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1564288","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"article-number":"1564288"}}